Mexico Diabetes Care Devices Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Mexico Diabetes Care Devices Market is segmented into monitoring devices (self-monitoring blood glucose devices (glucometer devices, blood glucose test strips, and lancets), continuous glucose monitoring devices (sensors and durables)), management devices (insulin pumps (insulin pump devices, insulin pump reservoir, and infusion set), insulin syringes, cartridges in reusable pens, disposable pens, and jet injectors). The report offers the value (in USD million) and volume (in units million) for the above segments.

Mexico Diabetes Care Devices Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Mexico Diabetes Care Devices Market Size

View Global Report
Mexico Diabetes Care Devices Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Historical Data Period 2019 - 2023
Market Size (2025) USD 533.08 Million
Market Size (2030) USD 712.71 Million
CAGR (2025 - 2030) 5.98 %

Major Players

Mexico Diabetes Care Devices Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Mexico Diabetes Care Devices Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Mexico Diabetes Care Devices Market Analysis

The Mexico Diabetes Care Devices Market size is estimated at USD 533.08 million in 2025, and is expected to reach USD 712.71 million by 2030, at a CAGR of 5.98% during the forecast period (2025-2030).

The COVID-19 pandemic has had a notable impact on the diabetes care devices market. Diabetes is a chronic condition demanding self-management and care, which involves regular attention to food, physical activity, blood sugar monitoring, and the use of medications. People with chronic diseases such as diabetes mellitus and obesity have a worse prognosis of COVID-19. Diabetic people are twice as likely to have their comorbid conditions worsened and consequently die. 

The healthcare system must be better organized for more severe cases of COVID-19 as studies suggest that inadequate glycemic control increases the risk of undesired outcomes in diabetic patients with SARS-CoV-2 infection. The prevalence of diabetes in people hospitalized with COVID-19 infection and the recognition that improved glycemic control might improve outcomes and reduce the length of stay in patients with COVID-19 have underlined the importance of diabetes care devices.

According to IDF Diabetes Atlas 2021, the prevalence of diabetes in Mexico has now reached 16.9% or one in six adults. In 2021, an estimated 14 million adults in Mexico are living with diabetes - a rise of 10% in the past two years. Additionally, 11 million adults in the country have Impaired Glucose tolerance (IGT), which places them at high risk of developing type 2 diabetes. Diabetes-related health expenditure in Mexico has reached USD 20 billion, putting it in the top ten countries or territories with the highest total health expenditure. Under half (47.5%) of people living with diabetes in the country are undiagnosed.

When diabetes is undetected or inadequately treated, people with diabetes are at risk of serious and life-threatening complications, such as heart attack, stroke, kidney failure, blindness, and lower-limb amputation. These result in reduced quality of life and higher healthcare costs and lead to a greater need for access to care. In Mexico, diabetes, especially Type 2, became a healthcare burden as it is the primary cause of death among women and the secondary cause of death among men. Obesity, sedentarism, bad eating habits, genetics, family background, and age are among the factors that lead to developing diabetes.

Thus, the aforementioned factors are set to increase the Brazil diabetes care device market's growth.

Mexico Diabetes Care Devices Industry Overview

The Mexico diabetes care devices market is semi-consolidated, with few significant and generic players. Manufacturers drove constant innovations to compete in the market. The major players, such as Abbott and Medtronic, underwent many mergers, acquisitions, and partnerships to establish market dominance while adhering to organic growth strategies. It is evident from the R&D spending of these companies.

Mexico Diabetes Care Devices Market Leaders

  1. Abbott Diabetes Care

  2. Medtronic PLC

  3. Eli Lilly and Company

  4. Roche Diabetes Care

  5. Novo Nordisk A/S

  6. *Disclaimer: Major Players sorted in no particular order
Mexico Diabetes Care Devices Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Mexico Diabetes Care Devices Market News

  • October 2022: Becton, Dickinson, and Company and Biocorp signed an agreement to use connected technology to track adherence to self-administered drug therapies, like biologics. To support biopharmaceutical companies in their efforts to improve the adherence and outcomes of injectable drugs, the two companies will integrate Biocorp's Injay technology. It is a solution designed to capture and transmit injection events using Near Field Communication technology to the BD UltraSafe Plus Passive Needle Guard used with pre-fillable syringes.
  • June 2022: Abbott announced that it's developing a new bio-wearable that will continuously monitor glucose and ketone levels in one sensor. The glucose-ketone sensor will be the same size as Abbott's FreeStyle Libre 3 sensor, the world's smallest and thinnest continuous glucose monitoring sensor. It will connect to Abbott's digital ecosystem, including personal and caregiver mobile apps and cloud-based data management software for remote monitoring by healthcare professionals.

Mexico Diabetes Care Devices Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
  • 4.3 Market Restraints
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products and Services
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION

  • 5.1 Monitoring Devices
    • 5.1.1 Self-monitoring Blood Glucose Devices
    • 5.1.1.1 Glucometer Devices
    • 5.1.1.2 Blood Glucose Test Strips
    • 5.1.1.3 Lancets
    • 5.1.2 Continuous Glucose Monitoring
    • 5.1.2.1 Sensors
    • 5.1.2.2 Durables
  • 5.2 Management Devices
    • 5.2.1 Insulin Pump
    • 5.2.1.1 Insulin Pump Device
    • 5.2.1.2 Insulin Pump Reservoir
    • 5.2.1.3 Infusion Set
    • 5.2.2 Insulin Syringes
    • 5.2.3 Cartridges in Reusable pens
    • 5.2.4 Insulin Disposable Pens
    • 5.2.5 Jet Injectors
  • 5.3 Distribution Channel
    • 5.3.1 Online
    • 5.3.2 Offline

6. MARKET INDICATORS

  • 6.1 Type-1 Diabetes Population
  • 6.2 Type-2 Diabetes Population

7. COMPETITIVE LANDSCAPE

  • 7.1 Company Profiles
    • 7.1.1 Abbott Diabetes Care
    • 7.1.2 Roche
    • 7.1.3 Lifescan
    • 7.1.4 Medtronic
    • 7.1.5 Arkray Inc.
    • 7.1.6 Ascensia Diabetes Care
    • 7.1.7 Novo Nordisk A/S
    • 7.1.8 Eli Lilly
    • 7.1.9 Insulet Corporation
    • 7.1.10 Sanofi
    • 7.1.11 Rossmax International Ltd
  • *List Not Exhaustive
  • 7.2 Company Share Analysis
    • 7.2.1 Self-monitoring Blood Glucose Devices
    • 7.2.1.1 Abbott Diabetes Care
    • 7.2.1.2 LifeScan
    • 7.2.1.3 Others
    • 7.2.2 Continuous Glucose Monitoring Devices
    • 7.2.2.1 Abbott Diabetes Care
    • 7.2.2.2 Medtronic PLC
    • 7.2.2.3 Others
    • 7.2.3 Insulin Devices
    • 7.2.3.1 Insulet Corporation
    • 7.2.3.2 Novo Nordisk A/S
    • 7.2.3.3 Others

8. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Mexico Diabetes Care Devices Industry Segmentation

Diabetes care devices are the hardware, equipment, and software used by diabetes patients to regulate blood glucose levels, prevent diabetes complications, lessen the burden of diabetes, and enhance the quality of life. The Mexico Diabetes Care Devices Market is segmented into monitoring devices (self-monitoring blood glucose devices (glucometer devices, blood glucose test strips, and lancets), continuous glucose monitoring devices (sensors and durables)), management devices (insulin pumps (insulin pump devices, insulin pump reservoir, and infusion set), insulin syringes, cartridges in reusable pens, disposable pens, and jet injectors). The report offers the value (in USD) and volume (in units) for the above segments.

Monitoring Devices Self-monitoring Blood Glucose Devices Glucometer Devices
Blood Glucose Test Strips
Lancets
Continuous Glucose Monitoring Sensors
Durables
Management Devices Insulin Pump Insulin Pump Device
Insulin Pump Reservoir
Infusion Set
Insulin Syringes
Cartridges in Reusable pens
Insulin Disposable Pens
Jet Injectors
Distribution Channel Online
Offline
Need A Different Region or Segment?
Customize Now

Mexico Diabetes Care Devices Market Research FAQs

How big is the Mexico Diabetes Care Devices Market?

The Mexico Diabetes Care Devices Market size is expected to reach USD 533.08 million in 2025 and grow at a CAGR of 5.98% to reach USD 712.71 million by 2030.

What is the current Mexico Diabetes Care Devices Market size?

In 2025, the Mexico Diabetes Care Devices Market size is expected to reach USD 533.08 million.

Who are the key players in Mexico Diabetes Care Devices Market?

Abbott Diabetes Care, Medtronic PLC, Eli Lilly and Company, Roche Diabetes Care and Novo Nordisk A/S are the major companies operating in the Mexico Diabetes Care Devices Market.

What years does this Mexico Diabetes Care Devices Market cover, and what was the market size in 2024?

In 2024, the Mexico Diabetes Care Devices Market size was estimated at USD 501.20 million. The report covers the Mexico Diabetes Care Devices Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Mexico Diabetes Care Devices Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Mexico Diabetes Care Devices Industry Report

Statistics for the 2025 Mexico Diabetes Care Devices market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Mexico Diabetes Care Devices analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.